Funds holding ABVC BIOPHARMA INC
ISIN US00091F3047 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 407.9K $
- Share of capital
- 1.4 % of 26.7M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 190,574 | 184.9K $ | 0.00 % | 0.71 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 105,944 | 138.8K $ | 0.00 % | 0.40 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 31,053 | 40.7K $ | 0.12 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 27,132 | 35.5K $ | 0.10 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 6,128 | 8K $ | 0.02 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | -2 | 360,831 | -0.7 % |
| 2026Q1 | 7 | +1 | 363,231 | +23.1 % |
| 2025Q4 | 6 | +2 | 295,094 | +44.2 % |
| 2025Q3 | 4 | 0 | 204,665 | +64.1 % |
| 2025Q2 | 4 | 0 | 124,710 | -1.2 % |
| 2025Q1 | 4 | 0 | 126,232 | +24.6 % |
| 2024Q4 | 4 | 0 | 101,288 | +47.2 % |
| 2024Q3 | 4 | 0 | 68,817 | -0.2 % |
| 2024Q2 | 4 | +1 | 68,947 | +47.6 % |
| 2024Q1 | 3 | 0 | 46,727 | +45.6 % |
| 2023Q4 | 3 | 32,090 |
Institutional managers
10 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 221,169 | 214.6K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 95,100 | 92.3K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 72,800 | 70.6K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 56,442 | 54.8K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 32,087 | 31.1K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 21,023 | 20.4K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 12,227 | 11.9K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 10,547 | 10.2K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 5,423 | 5.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 1,771 | 1.7K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding ABVC BIOPHARMA INC". https://titelia.com/en/stocks/abvc-biopharma-inc-US00091F3047